DCT

1:22-cv-01549

Janssen Biotech Inc v. Amgen Inc

General
Filed
11/29/22
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit830 Patent
Judge
Period
PO Win Rate
--
45%